Intrinsiqq
Lemaitre Vascular Inc. logo

Lemaitre Vascular Inc.

LMAT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$1.85B
EPS$2.76
P/E29.36
P/FCF27.62
EV/EBITDA19.37
FCF Yield3.6%
Div. Yield1.17%
Net Debt/FCF-3.0x
Lemaitre Vascular Inc. intrinsic value
52-Week Range
$78.80$117.39

Profitability & Returns

Revenue (TTM)

$269M

▲ +13.5% YoY

Net Income (TTM)

$63M

▲ +31.1% YoY

Op. Margin

27.73%

▲ +3.4pp YoY

ROIC

9.34%

▼ -0.2pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$67M

▲ +100.4% YoY

Op. Cash Flow (TTM)

$76M

▲ +84.1% YoY

Net Debt

-$201M

Net Cash Position

Cash & Equiv.

$390M

5Y CAGR: +14.0%

5Y CAGR: +18.5%

Continue Research

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with LMAT

CompareIntrinsic value
KIDSOrthoPediatrics Corp.
$31.76-1.43%45
CERSCerus Corporation
$2.02-5.16%32
SKINSkinHealth Systems Inc.
$15.71+51.79%42
MDXGMiMedx Group, Inc.
$3.31+0.91%18
SIBNSi-Bone Inc.
$24.24-0.12%40
ANGOAngiodynamics Inc.
$11.73-0.68%40
HTFLHeartFlow, Inc.
$52.40+0.87%49
TMCITreace Medical Concepts, Inc.
$4.03-3.59%14

Held by ETFs

LMAT is in 72 US ETFs. The largest of them, with LMAT's weight in each:

Lemaitre Vascular (LMAT) in four numbers

Fair value (earnings)
$119.27
Price $80.89 is 32% below it.
Intrinsic Value
Quality score
77/100
Best check: revenue growth, 13.6%. Weakest: share count change, 4.1%.
Quality
Dividend (FY2025)
$0.80
0.99% yield, raised at least 14 years in a row.
Dividends
P/E
29.36
Price to free cash flow 27.62.
Financials

Questions about Lemaitre Vascular

Is Lemaitre Vascular (LMAT) overvalued?

At $80.89, Lemaitre Vascular's price is 32% below the $119.27 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 29.36 times earnings and 27.62 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Lemaitre Vascular's fair value?

Intrinsiqq's calculator puts Lemaitre Vascular's fair value at $119.27 a share. It grows earnings per share 17.2% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $89.45. Every input can be changed on the Intrinsic Value tab.

Is Lemaitre Vascular a high-quality business?

Lemaitre Vascular scores 77 out of 100 on Intrinsiqq's quality score, which makes it a solid business on these measures. The score blends 8 checks computed from SEC filings. Its best check is revenue growth at 13.6%, and its weakest is share count change at 4.1%. The Quality tab shows every check against its target.

Does Lemaitre Vascular (LMAT) pay a dividend, and how much?

Yes. Lemaitre Vascular (LMAT) pays a dividend: $0.80 per share for fiscal 2025, a dividend yield of 0.99% at the latest close. It has raised its dividend per share for at least 14 years in a row, growing at 16.1% a year over the last 5 years. The payout takes about 34.2% of earnings.

Source: 10-Q filed 2 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in LMAT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LMAT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.